Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Erie Indemnity Company's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $12.5B | |
|---|---|---|
| P/E (forward) | 26.7x |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $2.63B | $2.84B | $3.27B | $3.80B | $4.07B | +11.5% |
| Gross profit | $2.70B | $376.2M | $520.3M | $676.5M | $640.8M | -30.2% |
| Operating income | $318.1M | $376.2M | $520.3M | $676.5M | $717.2M | +22.5% |
| Net income | $297.9M | $298.6M | $446.1M | $600.3M | $559.3M | +17.1% |
| EPS (diluted) | $5.61 | $6.08 | $8.69 | $11.49 | $12.24 | +21.5% |
| EBITDA | $-286.1M | $428.4M | $600.2M | $766.3M | $787.4M | — |
| R&D | $0 | $0 | $0 | — | — | +10.2% |
| SG&A | $58.3M | $668.3M | $737.1M | $806.3M | $74.1M | +6.2% |
Recent company headlines from major financial publishers.
In the base scenario, management fee revenue grows steadily in line with regional premium expansion while operating margins remain stable. Reinvestment moderates gradually, aligning intrinsic worth with Fair value $151.31 against the share price at analysis $239.05.
In the bull scenario, policyholder expansion into contiguous states accelerates while modern software deployments streamline administrative operations. Capital spending normalizes toward depreciation, releasing free cash flow and supporting Potential value $226.92.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.0% | $188 | $206 | $230 | $267 | $327 |
| 6.0% | $158 | $168 | $180 | $197 | $220 |
| 7.0% | $138 | $144 | $151 | $161 | $172 |
| 8.0% | $123 | $127 | $132 | $138 | $145 |
| 9.0% | $112 | $115 | $118 | $122 | $127 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
